FDA Inspection
Adare Pharmaceuticals SrlAdare Pharmaceuticals Srl – FDA Inspection, Feb 24, 2017
Record Details
This FDA Inspection record concerns Adare Pharmaceuticals Srl, with an inspection on February 24, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 75dde054-ec24-489f-a35c-ec53c5804795
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1006241
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.160(b)(3)Drug product sample
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Adare Pharmaceuticals Srl
5| Date | Classification | Office | Project area |
|---|---|---|---|
| October 28, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 13, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 30, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 19, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 9, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Adare Pharmaceuticals Srl
- FDA Inspection 1204801 - 2022-10-28
- FDA Inspection 1098299 - 2018-04-13
- FDA Inspection 883317 - 2014-05-30
- FDA Inspection 793805 - 2012-07-19
- FDA Inspection 622477 - 2009-10-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.